Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells

Diabetologia

Volumn 44, Issue 3, 2001, Pages 325-332

  Chen, M C ^a   Proost, P ^b   Gysemans, C ^c   Mathieu, C ^c   Eizirik, D L ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Beta cell; Diabetes mellitus; Human islets; Interferon ; Interleukin 1; MCP 1; Nitric oxide; NOD mice; Pancreatic islets; Polymerase chain reaction

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE INHIBITOR; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SELECTION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OMEGA-N-METHYLARGININE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREDIABETIC STATE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035079807     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051622     Document Type: Article

References (56)

1. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation
2. Pathologic anatomy of the pancreas in juvenile diabetes mellitus
3. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis
4. Human chemokines: An update
5. Monocyte chemoattractant protein-1
6. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
7. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
8. Regulation and expression of chemokines: Potential role in glomerulonephritis
9. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis
10. -/- mice reveals a role for chemokines in the initiation of atherosclerosis
11. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
12. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1
13. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1
14. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: Abrogation by a second transgene expressing systemic MCP-1
15. The role of interleukin-1 in the pathogenesis of IDDM
16. Identification of IL-1β-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA
17. A new in vitro model for the study of pancreatic A and B cells
18. Effect of nutrients, hormones and serum on survival of rat islet β-cells in culture
19. PD 098059 is a specific inhibitor of the activation of mitogen activated protein kinase kinase in vitro and in vivo
20. A synthetic inhibitor of the mitogen-activated protein kinase cascade
21. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
22. Interleukin-1β-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases
23. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells
24. Effect of interferon-γ and glucose on major histocompatibility complex class I and class II expression by pancreatic β- and non-β-cells
25. Implantation of standardized β-cell grafts in a liver segment of IDDM patients: Graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft
26. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation
27. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation
28. Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release
29. Contribution of ductal cells to cytokine responses by human pancreatic islets
30. 3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes
31. 3, KH1060
32. 3 in combination with a short induction course of cyclosporin A
33. 3 analog and cyclosporine
34. 3 prevents insulitis in NOD mice
35. 3
36. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
37. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR
38. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: Identification of MCP-2 (6-76) as a natural chemokine inhibitor
39. Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms
40. Interferon-γ induces interleukin-1 converting enzyme expression in pancreatic islets by an interferon regulatory factor-1-dependent mechanism
41. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1
42. c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells
43. In vivo properties of monocyte chemoattractant protein-1
44. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle
45. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
46. Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells
47. The mitogen-activated protein kinase p38 is necesssary for interleukin 1β-induced monocyte chemoattractant protein 1 expression by human mesangial cells
48. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-α-induced expression of monocyte-chemoattractant protein-1 in endothelial cells
49. Nuclear factor-κB p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene
50. Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury
51. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
52. Monocyte chemotactic proteins 1, 2 and 3
53. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic β-cells
54. The NOD mouse as a model of type I diabetes
55. Evidence for initial involvement of macrophage in development of insulitis in NOD mice
56. Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase